<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T22:31:30Z</responseDate>
  <request identifier="oai:figshare.com:article/33920446" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33920446</identifier>
        <datestamp>2026-09-18T05:36:28Z</datestamp>
        <setSpec>category_19</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Table 1_Scutellarin attenuates high glucose-induced edema and inflammation in retinal Müller cells via AQP4/Kir4.1 restoration and TLR4/MyD88/NF-κB inhibition.docx</dc:title>
          <dc:creator>Yunhua Tang (8376537)</dc:creator>
          <dc:creator>Shan Ding (3446876)</dc:creator>
          <dc:creator>Wenyan Peng (3625874)</dc:creator>
          <dc:creator>Meichu Wu (25070179)</dc:creator>
          <dc:creator>Yongqi Mao (22520079)</dc:creator>
          <dc:creator>Wenxin Yang (5821358)</dc:creator>
          <dc:creator>Xiaoyang Li (1316730)</dc:creator>
          <dc:creator>Fuwen Zhang (575612)</dc:creator>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>AQP4/Kir4.1</dc:subject>
          <dc:subject>diabetic macular edema</dc:subject>
          <dc:subject>diabetic retinopathy</dc:subject>
          <dc:subject>retinal Müller cells</dc:subject>
          <dc:subject>Scutellarin</dc:subject>
          <dc:subject>TLR4/MyD88/NF-κB/VEGFA</dc:subject>
          <dc:description>Background&lt;p&gt;Diabetic retinopathy (DR) is a metabolic eye disease closely linked to inflammation and oxidative stress, potentially causing vision decline or blindness. Scutellarin (SCU), a major flavonoid extracted from Erigeron breviscapus, possesses anti-inflammatory and antioxidant properties; however, its protective mechanisms against retinal Müller cell (RMC) injury in DR remain unclear.&lt;/p&gt;Objective&lt;p&gt;To investigate the protective effects and underlying mechanisms of SCU against high-glucose(HG)-induced edema and inflammation in retinal Müller cells (RMCs).&lt;/p&gt;Materials and Methods&lt;p&gt;Primary RMCs were isolated from newborn 3–5-day-old Sprague-Dawley (SD) rats and exposed 100 mmol/L HG to establish an in vitro injury model. Groups included control, model (HG), low-dose (HG+25 μmol/L SCU), and high-dose (HG+50 μmol/L SCU). Cell viability, migration capacity, Na&lt;sup&gt;+&lt;/sup&gt;-K&lt;sup&gt;+&lt;/sup&gt;-ATPase activity, and apoptosis were assessed using CCK-8 assays, scratch wound healing assays, enzymatic activity assays, and flow cytometry, respectively. The expression and distribution of AQP4, Kir4.1, and molecules associated with the TLR4/MyD88/NF-κB/VEGFA pathway were evaluated via immunofluorescence, Western blot, and qRT-PCR.&lt;/p&gt;Results&lt;p&gt;HG exposure significantly suppressed RMC viability, induced apoptosis, disrupted the functional coupling of AQP4/Kir4.1, and activated the TLR4/MyD88/NF-κB/VEGFA signaling pathway. SCU treatment dose-dependently reversed these pathological changes, restored Na&lt;sup&gt;+&lt;/sup&gt;-K&lt;sup&gt;+&lt;/sup&gt;-ATPase activity and the expression balance of AQP4/Kir4.1, and inhibited the excessive activation of the inflammatory pathway.&lt;/p&gt;Conclusion&lt;p&gt;The protective effects of SCU are significantly associated with the restoration of AQP4/Kir4.1 homeostasis and the suppression of the TLR4/MyD88/NF-κB/VEGFA pathway, suggesting its potential as a multi-target candidate drug for delaying the progression of DR.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T05:36:28Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fphar.2026.1923023.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Table_1_Scutellarin_attenuates_high_glucose-induced_edema_and_inflammation_in_retinal_M_ller_cells_via_AQP4_Kir4_1_restoration_and_TLR4_MyD88_NF-_B_inhibition_docx/33920446</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
